NIP
OPTN

Nicholas Investment Partners’s OptiNose OPTN Stock Holding History

Nicholas Investment Partners’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,269
Closed -$3.78M – 235
2018
Q3 		$3.78M Sell
20,269
-255
-1% -$72.7K 0.3% 130
2018
Q2 		$8.61M Buy
+20,524
New +$6.92M 0.61% 29

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nicholas Investment Partners's OPTN Position: Q4 2018 in Review

Nicholas Investment Partners sold out of OptiNose (OPTN) in Q4 2018, closing a stake of 20,269 shares — an estimated $3.78M sold.

Nicholas Investment Partners first reported a position in OPTN in Q2 2018 and held it in 2 quarters. The position peaked at $8.61M in Q2 2018. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2018.

  • Nicholas Investment Partners reported no remaining OptiNose position as of Q4 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 20,269 OptiNose shares in Q4 2018, an estimated $3.78M.
  • Nicholas Investment Partners first reported a position in OptiNose in Q2 2018 and held it in 2 quarters.
  • Nicholas Investment Partners's OptiNose position peaked at $8.61M in Q2 2018.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2018.

Based on Nicholas Investment Partners's 13F filing for Q4 2018, filed 14 Feb 2019.